Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 21.3713.5264.41--

What is the latest Core EBITDA Growth ratio of AARTI PHARMALABS ?

The latest Core EBITDA Growth ratio of AARTI PHARMALABS is 21.37 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202521.37
Mar202413.52
Mar202364.41
Mar2022-
Mar2021-

How is Core EBITDA Growth of AARTI PHARMALABS Trending?

Years Core EBITDA Growth % Change
Mar2025 21.37
58.06
Mar2024 13.52
-79.01
Mar2023 64.41
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Growth ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹5,709.1 Cr -2% -20.2% -29.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,933.0 Cr -0.7% -3.6% 6% Stock Analytics
DIVIS LABORATORIES ₹175,833.0 Cr 1.1% -1.2% -0.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,549.0 Cr 1.6% 1.4% 36.7% Stock Analytics
CIPLA ₹113,155.0 Cr 0.7% 2.6% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,654.0 Cr -0.9% -2.5% 1.2% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-2%

-20.2%

-29.3%

SENSEX

-0.7%

-3.6%

-9.1%


You may also like the below Video Courses